Skip to Main Content

Healthcare Engineering Simulation

Advancing In Silico Medicine

Modeling and simulation are proven ways to address the high and unsustainable costs and time required for design and regulatory approval of increasingly complex healthcare solutions. This in silico approach maximizes patient safety while making healthcare more affordable.

 

Accelerating Innovation in Healthcare With In Silico Medicine

With a patient’s well-being and even life at stake, product failure is not an option. Realizing the benefits of in silico medicine by applying engineering simulation throughout development and the regulatory approval process, accelerates innovation, reduces cost and shortens time to market while meeting safety standards and product deadlines.

  • check-icon-solid.png
    Medical Devices
  • check-icon-solid.png
    Clinical Applications
  • check-icon-solid.png
    Pharma/Biopharma

Simulation Solutions That Serve the Entire Healthcare Industry

Image of two doctors examining results

Medical Devices

Engineering simulation of medical devices and their interaction with the body accelerate innovation, design optimization and regulatory approval processes.

Learn More

Clinical Applications

Clinically validated, predictive computer models of surgical and medical protocols applied to patient-specific models deliver improved patient outcomes.

Learn More

Pharma and Biopharma

Physics based simulation optimizes drug production processes and provides scaled delivery mechanisms to the target population.

Learn More

 

 

 

 

Applications

The adoption of in silico methods is pervasive across all healthcare sectors. Engineering simulation is used during discovery and ideation, invention and prototyping, pre-clinical, clinical, and regulatory decision-making.

For modern connected devices, such as wearable insulin pumps, in silico methods help designers optimize catheters, needles, embedded software and insulin absorption.

Modeling and simulation have also been adopted to optimize orthopedic and cardiovascular implants, respiratory devices, hospital equipment and drug manufacturing and delivery.

혼합

정형외과

환자의 생리학적 특성에 일치하고 MRI 호환성 요구 사항을 준수하는 혁신적이고 내구적인 임플란트를 개발합니다. 

심혈관

심혈관

새로운 심혈관 및 임플란트 의료 기기의 빠르고 신뢰성 있는 검사를 위한 혁신적 솔루션. 

혼합

혼합

Ansys 유체 혼합 시뮬레이션 툴은 하나 이상의 유사유체(fluid-like) 물질의 혼합 및 배합 프로세스를 모델링하는 데 도움을 줍니다.

Disruption in Healthcare is Here

In silico medicine is set to drastically change the way engineers approach healthcare solutions.

Disruption in Healthcare is Here

BUSINESS BENEFITS

Simulating the performance of drugs, devices and therapies in a low-risk, cost-effective virtual environment can develop disruptive innovations much faster and at lower cost. Healthcare pioneers have repeatedly reported returns on investment of greater than 500%.

In silico medicine— synonymous with “computational” medicine—is revolutionizing the equipment and procedures of the health care industry. This approach takes advantage of digital modeling and simulation. Many industry leaders have turned to Ansys software to pursue this approach as it offers fast product development cycles along with reduced costs.

The medical industry has only recently adopted simulation-based techniques. In this whitepaper you’ll see how this is pushing the boundaries of health care solutions. For example, simulation is responsible for medical innovative approaches such as Virtual Human Laboratory (VHL) which allows users to understand the effects of implants or drugs, in a digital workspace. This reduces risks associated with traditional testing and can even assist with FDA approval.   It is a win-win situation that can increase safety and performance while simultaneously reducing development costs and time to market.

The Rise of In Silico Medicine

To accelerate adoption and ensure the highest safety standards are maintained, the leading medical device and pharma companies, in collaboration with the regulators and simulation industry, have developed  best practices to enable dramatic cost and time to market reduction while maximizing patient safety.

2020-12-other-icon-block.jpg

‘Virtual Human Laboratory’: A Safer Way to Understand Solutions Performance

Creating and validating virtual anatomic models enables companies to test their prototypes under realistic physiologic conditions.

2020-12-other-icon-block.jpg

‘In Silico Testing’ Provides Reliable Results

To address human variability, new prototypes can be tested using cohorts of virtual patients that are representative of the target population.

2020-12-other-icon-block.jpg

‘Simulation-Driven Regulatory Approval’ opens the doors to digital evidences.

As regulatory agencies consider digital evidence, it is crucial to create credible, verified and validated models to address regulator questions and concerns.

2020-12-other-icon-block.jpg

Personal Digital Avatars Advance Personalized Medicine

The proliferation of connected medical devices promises to enable the digital twin of every human. A simulation powered personal digital avatar will be the key to the future of accurate predictive and preventive medicine.

Featured Events

2020-12-webinar-icon-block.jpg

Healthcare Webinar Series

This healthcare industry webcast series shares the knowledge and experience of Ansys experts and our partners to guide you in the strategic adoption of engineering simulation.

불가능을 가능하게 만들 준비가 되셨나요?

문의하기

* = 필수 항목

문의해 주셔서 감사합니다!

We’re here to answer your questions and look forward to speaking with you. A member of our Ansys sales team will contact you shortly.

Racecars on a track